Preferred
(EDT)
Other
Cancer Stem Cells: Clinical Translation
Molecular Understanding and Therapeutic Targeting of Prostate Cancer Cell Heterogeneity
9:50 AM - 10:15 AM EDT
Friday, May 21, 2021Speaker
Dean Tang, PhD
Roswell Park Cancer Institute
Cancer Stem Cells: Clinical Translation
Cancer Stem Cells as Biomarkers for Radiotherapy Outcome and Targets for Combined Treatments
10:15 AM - 10:40 AM EDT
Friday, May 21, 2021Speaker
Anna Dubrovska, PhD
University Hospital Carl Gustav Carus
Cancer Stem Cells: Clinical Translation
IDH1 Mutation Predisposes Distinctive Therapeutic Vulnerabilities in Glioma Stem Cells
10:40 AM - 11:05 AM EDT
Friday, May 21, 2021Speaker
Chunzhang Yang, PhD
NCI, National Institutes of Health
Cancer Stem Cells: Clinical Translation
Characterization and Targeting of Distinct Subpopulations Driving Tumor Progression and Drug Resistance in Advanced Solid Tumors
11:05 AM - 11:30 AM EDT
Friday, May 21, 2021Speaker
Wolf Ruprecht Wiedemeyer, PhD
AbbVie, Inc.
Cancer Stem Cells: Clinical Translation
